Restricted Research - Award List, Note/Discussion Page

Fiscal Year: 2018

1700  University of Houston  (75518)

Principal Investigator: Bradley K McConnell

Total Amount of Contract, Award, or Gift (Annual before 2011): $ 475,000

Exceeds $250,000 (Is it flagged?): Yes

Start and End Dates: 2/1/18 - 1/31/21

Restricted Research: YES

Academic Discipline: PHARMACOLOGICAL & PHARMACEUTIC

Department, Center, School, or Institute: DEAN, PHARMACY

Title of Contract, Award, or Gift: GRAVIN SIGNALOSOME IS A NOVEL THERAPEUTIC DRUG TARGET FOR THE TREATMENT OF HEART FAILURE

Name of Granting or Contracting Agency/Entity: Kleberg Foundation

Program Title: 2017 FALL MEDICAL RESEARCH APPLICATION

Note:

1.1.1 - This project will focus on one particular AKAP, gravin. Gravin targets PKA, among other proteins, to beta2-ARs and is involved in the desensitization/resensitization cycling of the receptor.

Discussion: No discussion notes

 

Close Window